FDA Updates

What pharmacists need to know about the new antibody approved for multi-drug-resistant HIV-1.

FDA approves apalutamide for castration-resistant prostate cancer.

Netarsudil opthalmis solution (Rhopressa, Aerie Pharmaceuticals), is approved by the FDA for treatment of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension.

Vabomere combines a carbapenem and a beta-lactamase inhibitor as a treatment for complicated urinary tract infections.

Emicizumab-kxwh brings together factors IXa and X to restore the function of the missing activated factor VIII and the blood clotting process.

Delafloxacin (Baxdela) for treatment of acute bacterial skin and skin structure infections including cellulitis, wound infection, major cutaneous abscess, and burn infection.

Abilify MyCite is the first drug to contain a bit of technology that reports that it has been taken as prescribed.

Edaravone has been approved for patients with amyotropic lateral sclerosis.

The FDA has approved ocrelizumab for treating relapsing forms of multiple sclerosis and primary progressive multiple sclerosis.

More information could help save lives.

New technology is helping patients, nurses, and pharmacists alike.

New product uses new technology to break down earwax

Plecanatide: Approved for Chronic Idiopathic Constipation

Sugammadex reverses vecuronium and rocuronium, two drugs used to facilitate endotracheal intubation in surgery.

Americans spend billions of dollars on products to address specific hair and scalp concerns each year-whether that be color, condition, or appearance.

New branded drugs, new generics.

The summer months can be a time of increased activity for many people, as warmer temperatures usher in numerous outdoor events that can be more strenuous and bring us closer to nature.

New branded drugs, new generics

New OTC products for eyes and ears.

Most pharmacy shelves stock numerous alternative treatments for simple skin problems. Here are a few of the newer ones.

New Rx, indications, generics, and OTC

New Rx, formulation, biosimilar, indication, generics, OTC, and device/app.

Plenty of options on the pharmacy shelves to keep those dogs from barking.

New Rx, new generics, new formulations, and new OTC

New drugs, formulations, generics, and devices.

New Rx, new indications, new formulations, and new generics

Products for adults and children line pharmacy shelves, with plenty of child-friendly options for parents teaching oral hygiene to the young.

According to the Centers for Disease Control, adults in the United States have an average of two to three colds per year. Children have even more.